{{Rsnum
|rsid=16949649
|Gene=NME1
|Chromosome=17
|position=51152947
|Orientation=plus
|GMAF=0.4027
|Gene_s=NME1,NME1-NME2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 14.2 | 43.4 | 42.5
| HCB | 19.0 | 50.4 | 30.7
| JPT | 18.6 | 47.8 | 33.6
| YRI | 12.2 | 49.0 | 38.8
| ASW | 10.5 | 47.4 | 42.1
| CHB | 19.0 | 50.4 | 30.7
| CHD | 23.9 | 45.9 | 30.3
| GIH | 3.0 | 32.7 | 64.4
| LWK | 23.6 | 49.1 | 27.3
| MEX | 12.1 | 41.4 | 46.6
| MKK | 10.9 | 37.8 | 51.3
| TSI | 8.8 | 54.9 | 36.3
| HapMapRevision=28
}}{{PMID|18676749|OA=1
}} [[breast cancer]] 1,134 breast cancer patients recruited as part of the Shanghai Breast Cancer Study who were followed for a median of 7.1 years. [[rs16949649]](C) associated with higher breast cancer-specific mortality [hazard ratio (HR), 1.4; 95% confidence interval (95% CI), 1.1-1.9]

{{ neighbor
| rsid = 3760468
| distance = 183
}}

{{PMID Auto
|PMID=20599259
|Title=Significant association of genetic polymorphism of human nonmetastatic clone 23 type 1 gene with an increased risk of endometrial cancer
}}

{{PMID Auto
|PMID=20601538
|Title=Polymorphisms of human nonmetastatic clone 23 type 1 gene and neoplastic lesions of uterine cervix.
}}

{{PMID Auto
|PMID=22683585
|Title=nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
}}

{{PMID Auto
|PMID=22903495
|Title=Associations of non-metastatic cells 1 gene polymorphisms with lymph node metastasis risk of gastric cancer in Northern Chinese population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}